Abstract

AYURVEDIC PANCHAKARMA-BASED MULTIMODAL INTERVENTION FOR TYPE 2 DIABETES: GLYCEMIC CONTROL AND ANTIDIABETIC DRUG REDUCTION IN 67 PATIENTS — A RETROSPECTIVE ANALYSIS

*Dr. Bipin Gond, Dr. Prajakta Asnodkar

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a growing metabolic burden in India, with conventional pharmacotherapy achieving suboptimal glycemic targets while requiring lifelong medication escalation. Ayurveda conceptualizes Prameha — the classical analogue of diabetes mellitus — as a disorder rooted in Kapha-Medovaha Srotas dysfunction, amenable to intervention through Panchakarma, dietary correction, and herbal formulations. Real-world evidence from structured Ayurvedic multimodal protocols remains limited. Objectives: To evaluate the effect of a structured integrative Ayurvedic protocol — comprising BMI-stratified Panchakarma therapy (CDC-SP and CDC-KP), an 800 kcal low-carbohydrate Prameha diet, and individualized herbal medication — on glycemic, anthropometric, cardiometabolic, and insulin resistance parameters, and to quantify reduction in antidiabetic medications. Methods: Retrospective observational study of 67 T2DM patients treated at Madhavbaug Clinics, Mira Road. Panchakarma comprised Snehan (Neem Siddha Taila), Swedan (Dashmula Kwath), and Basti (Gudmar, Daru Haridra, Yashti Madhu) — Kwath-based in CDC-SP (BMI ≥23) or oil-based in CDC-KP (BMI

Keywords: Type 2 diabetes mellitus, Panchakarma, Prameha, Ayurveda, Basti, TG/HDL ratio, insulin resistance, HbA1c, antidiabetic drug reduction, very-low-calorie diet, Gudmar.